Paper36065342
Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype.
Barricklow Z and 3 others. Clin Cosmet Investig Dermatol, 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype. Papers, record 36065342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36065342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016058 | NCI NIH HHS | United States | P30CA016058 | PubMed | NIH RePORTER |
| T32 GM139784 | NIGMS NIH HHS | United States | T32GM139784 | PubMed | NIH RePORTER |
| UM1 CA186712 | NCI NIH HHS | United States | UM1CA186712 | PubMed | NIH RePORTER |
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21519009 | Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21519009 | PubMed |
| 2 | 11208853 | Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. | J Clin Oncol | 2001 | https://conductscience.org/library/papers/11208853 | PubMed |
| 3 | 7118080 | Ulceration and prognosis in cutaneous malignant melanoma. | Histopathology | 1982 | https://conductscience.org/library/papers/7118080 | PubMed |
| 4 | 24030740 | Maspin expression and melanoma progression: a matter of sub-cellular localization. | Mod Pathol | 2014 | https://conductscience.org/library/papers/24030740 | PubMed |
| 5 | 31529312 | The Sunbelt Melanoma Trial. | Ann Surg Oncol | 2020 | https://conductscience.org/library/papers/31529312 | PubMed |
| 6 | 31646109 | Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas. | Oncoimmunology | 2019 | https://conductscience.org/library/papers/31646109 | PubMed |
| 7 | 28842323 | Associations of Statins and Diabetes with Diagnosis of Ulcerated Cutaneous Melanoma. | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/28842323 | PubMed |
| 8 | 25344738 | Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. | Nat Med | 2014 | https://conductscience.org/library/papers/25344738 | PubMed |
| 9 | 21094463 | Neutrophils, from marrow to microbes. | Immunity | 2010 | https://conductscience.org/library/papers/21094463 | PubMed |
| 10 | 22198560 | Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. | Melanoma Res | 2012 | https://conductscience.org/library/papers/22198560 | PubMed |
| 11 | 28356599 | Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel. | Sci Rep | 2017 | https://conductscience.org/library/papers/28356599 | PubMed |
| 12 | 29278418 | Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma. | Br J Dermatol | 2018 | https://conductscience.org/library/papers/29278418 | PubMed |
| 13 | 21386910 | Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. | PLoS One | 2011 | https://conductscience.org/library/papers/21386910 | PubMed |
| 14 | 26662433 | Expression of microRNA-106b and its clinical significance in cutaneous melanoma. | Genet Mol Res | 2015 | https://conductscience.org/library/papers/26662433 | PubMed |
| 15 | 24572365 | Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. | Nature | 2014 | https://conductscience.org/library/papers/24572365 | PubMed |
| 16 | 21881483 | Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34. | Am J Surg Pathol | 2011 | https://conductscience.org/library/papers/21881483 | PubMed |
| 17 | 12789288 | PTEN signaling pathways in melanoma. | Oncogene | 2003 | https://conductscience.org/library/papers/12789288 | PubMed |
| 18 | 22137134 | Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. | Am J Surg | 2011 | https://conductscience.org/library/papers/22137134 | PubMed |
| 19 | 15976338 | The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. | J Clin Pathol | 2005 | https://conductscience.org/library/papers/15976338 | PubMed |
| 20 | 31366492 | MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas. | Anticancer Res | 2019 | https://conductscience.org/library/papers/31366492 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42870879 | Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42870879 | PubMed |
| 42452872 | The impairment of CD3+ T lymphocytes in sentinel lymph node of high-risk cutaneous melanoma patients in stage IIB and IIC. | J Pathol Transl Med | 2026 | https://conductscience.org/library/papers/42452872 | PubMed |
| 42247192 | Health-related quality of life in older survivors of melanoma: a SEER-MHOS study. | Qual Life Res | 2026 | https://conductscience.org/library/papers/42247192 | PubMed |
| 42186061 | Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes. | Genome Med | 2026 | https://conductscience.org/library/papers/42186061 | PubMed |
| 41508836 | Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients. | Acta Derm Venereol | 2026 | https://conductscience.org/library/papers/41508836 | PubMed |
| 41360775 | Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study. | Nat Commun | 2025 | https://conductscience.org/library/papers/41360775 | PubMed |
| 40984902 | Histopathological Subtypes of Cutaneous Melanoma: Prognostic and Molecular Implications. | Cureus | 2025 | https://conductscience.org/library/papers/40984902 | PubMed |
| 40377211 | Survival Correlates With Adjuvant Choice in Sentinel Node Positive Head and Neck Cutaneous Melanoma. | Laryngoscope | 2025 | https://conductscience.org/library/papers/40377211 | PubMed |
| 40275302 | Potential of CLSPN as a therapeutic target in melanoma: a key player in melanoma progression and tumor microenvironment. | J Transl Med | 2025 | https://conductscience.org/library/papers/40275302 | PubMed |
| 40150308 | Prognostic Insights in Feline Mammary Carcinomas: Clinicopathological Factors and the Proposal of a New Staging System. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40150308 | PubMed |
| 40004177 | Association of Plasma Lipid Patterns and LDL Cholesterol Levels with Breslow Thickness and Ulceration in Melanoma Patients. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40004177 | PubMed |
| 39672750 | Eccrine poroma versus eccrine porocarcinoma: a comparative study of clinicopathological features. | An Bras Dermatol | 2025 | https://conductscience.org/library/papers/39672750 | PubMed |
| 38859868 | Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/38859868 | PubMed |
| 37512052 | Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37512052 | PubMed |
| 36408152 | A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients. | Front Oncol | 2022 | https://conductscience.org/library/papers/36408152 | PubMed |
Genes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36065342
GET https://conductscience.org/api/papers/v1/36065342/references?page=2